The FDA granted orphan drug designation to cintredekin besudotox for glioblastoma, supporting further research for this ...

How Piramal Pharma is shaping resilient, patient-centric development across OSDs, HPAPIs, and sterile injectables.

FDA grants orphan drug designation to cintredekin besudotox, offering new hope for glioblastoma treatment with targeted ...

CMS has finalized several changes for the third round of Medicare drug price negotiations. The changes, outlined in a final guidance issued Sept.

Sharp Therapeutics is a preclinical-stage company developing first-choice small-molecule therapeutics for genetic diseases. The Company’s discovery platform produces small molecule compounds that ...

Napo Pharmaceuticals has submitted an orphan drug designation application to the U.S. Food and Drug Administration (FDA) for ...

Orphan drugs are therapeutics developed to address rare diseases typically defined by patient population thresholds that vary ...

The Trump administration issued a final plan Tuesday for how it will carry out the third round of the Medicare drug price ...

August 24, 2007 — The US Food and Drug Administration (FDA) has granted orphan drug designation for nitroimidazole PA-824 for the treatment of tuberculosis, 3'-deoxyadenosine for the treatment of ...

Aug. 1, 2005 — Europe has approved orphan drugs pegylated arginine deiminase for the treatment of hepatocellular carcinoma, soluble yeast beta-1,3/1,6-glucan for the prophylaxis of mucositis due to ...

JCR and MEDIPAL announced that the Ministry of Health, Labour and Welfare of Japan has granted orphan drug designation to ...